T-cell lymphomas
Clinical trials for T-cell lymphomas explained in plain language.
Never miss a new study
Get alerted when new T-cell lymphomas trials appear
Sign up with your email to follow new studies for T-cell lymphomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame rare blood cancers
Disease control Recruiting nowThis early-phase trial tests two drugs, ruxolitinib and duvelisib, together in people whose T- or NK-cell lymphoma has come back or stopped responding to treatment. The main goal is to find the safest dose of duvelisib when combined with a fixed dose of ruxolitinib. About 70 part…
Matched conditions: T-CELL LYMPHOMAS
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug cocktail aims to beat lymphoma without chemo
Disease control Recruiting nowThis study tests a combination of two drugs, GW5282 and golidocitinib, for people with T-cell lymphoma. The first part finds the safest dose; the second part compares the combo to standard chemotherapy. About 165 adults with newly diagnosed or relapsed disease will take part. The…
Matched conditions: T-CELL LYMPHOMAS
Phase 1/2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC